TrialInternational journal of obesity (2005)2012
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide.
A Astrup et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
278 papers cite itlatest 60 shown
this paperpooled ittrialcites it